Clinical trial

Loop Diuretic Dosage in Patients With Acute Heart Failure and Renal Failure: Conventional Versus Carbohydrate Antigen 125-guided Therapy (IMPROVE-HF)

NCT02643147

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention CA125 guided strategy Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Conventional Strategy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Loop Diuretic Dosage in Patients With Acute Heart Failure and Renal Failure: Conventional Versus Carbohydrate Antigen 125-guided Therapy (IMPROVE-HF)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-01-01

PhasePHASE4

Conditions

Heart Failureverified · MONDO: heart failure

Interventions

CA125 guided strategyDRUG

Conventional StrategyDRUG

Sponsors & collaborators

Fundación para la Investigación del Hospital Clínico de Valencialead sponsor

Mapped research locations

ValenciaSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02643147 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.